# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb® Drug Discovery Platform ActivMab® platfor...
Vaccinex shares are trading lower by 7.1%Thursday morning. The company announced a 1-for-14 reverse stock split.
Vaccinex, Inc., (NASDAQ:VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodeg...
Vaccinex shares are trading higher by 15% during Wednesday's session. The company announced a private placement transaction...